T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccineB 세포 림프종 환자에서 COVID-19 mRNA 백신을 여러 번 접종한 후 SARS-CoV-2 및 Omicron 변이체에 대한 T 세포 반응Case Reports Published on 2022-07-012022-09-11 Journal: Journal for immunotherapy of cancer [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody Antibody Response B cell B cells CD4 CD8 COVID-19 COVID-19 infections develop disease severity dose expected healthy subject healthy subjects Hematologic malignancy hematologic neoplasms humoral Immune escape immune system immunology Immunosuppression implication initial Lymphocytes lymphoma Messenger RNA mRNA mRNA vaccine multiple dose Neoplasms omicron Patient Patients with cancer protective immunity response SARS-CoV-2 SARS-CoV-2 virus T cell T cell response T cells T-lymphocytes the patient the SARS-CoV-2 virus the vaccine vaccination Vaccination strategy Vaccine Vaccines variant Viral Viral transmission while [DOI] 10.1136/jitc-2022-004953 PMC 바로가기 [Article Type] Case Reports
Short and mid-term SARS-CoV-2 antibody response after inactivated COVID-19 vaccine in hemodialysis and kidney transplant patients혈액 투석 및 신장 이식 환자에서 비활성화된 COVID-19 백신 후 단기 및 중기 SARS-CoV-2 항체 반응Observational Study Published on 2022-07-012022-09-12 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] acute respiratory syndrome Administered age Anti-spike antibody Antibody Response Antibody titer cohorts comparable Control CoronaVac coronavirus coronavirus disease COVID-19 COVID-19 vaccine death dialysis disease dose doses Efficacy first dose Follow-up group groups healthy control Hemodialysis homologous or heterologous Immunocompromised patients Immunoglobulin inactivated Inactivated vaccine incidence intensive care kidney Kidney disease kidney transplant kidney transplant recipient Kidney transplantation negative correlation Participants Patient patients peaked performed proportion prospective observational study SARAS-CoV-2 SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 vaccine Seroconversion significantly therapy Vaccination strategy Vaccine vaccine dose Vaccines was recorded [DOI] 10.1002/jmv.27714 PMC 바로가기 [Article Type] Observational Study
Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic reviewSARS-CoV-2 mRNA 백신 접종 후 6개월 후 체액성 면역 반응의 현저한 감소 특성: 체계적인 검토Review Published on 2022-07-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration age anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody anti-Spike IgG antibody Antibody Response Antibody titer Antibody titers appearance article binding domain BNT161b2 BNT162b2 booster Breakthrough infection breakthrough infections calculated characterization Comorbidities coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 mRNA Vaccination determine Effect Efficacy Evidence exhibited Factor finding highlight humoral humoral immune response Humoral immunity Humoral response IgG Immunoglobulin Immunoglobulin G independent independent of Kinetics Longitudinal data Messenger RNA Moderna mRNA mRNA 1273 mRNA BNT162b2 mRNA vaccination mRNA-1273 Participants peak levels Pfizer-BioNTech postvaccination presence of comorbidities reached reported respiratory second dose serostatus Serum level serum levels severe acute respiratory syndrome Coronavirus Sex systematic review Vaccination strategy Vaccine Vaccines variant waning immunity was performed [DOI] 10.1002/jmv.27688 PMC 바로가기 [Article Type] Review
A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine ResponseCOVID-19 백신의 4차 접종은 최적의 백신 반응을 보이지 않는 고형 장기 이식 수혜자들 사이에서 오미크론 변이체의 중화를 유도하지 않습니다Article Published on 2022-07-012022-09-11 Journal: Transplantation [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome angiotensin angiotensin-converting enzyme 2 anti-receptor-binding domain Anti-spike anti-spike antibody anti-Spike IgG Antibody Units binding antibody units booster vaccinations change Cohort coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine Delta delta variant domain dose ELISA full-length spike protein Health Organization healthy controls high risk Humoral response humoral responses IgG immune evasion Immunoglobulin increase Infection interquartile range Intervention Live virus median multiplex neutralization neutralizing capacity omicron Omicron variant Protective recipient respiratory response Seropositivity significantly increased significantly lower Solid solid organ solid organ transplant Spike proteins surrogate the vaccine Transplant Vaccination strategy Vaccine vaccine dose vaccine strain variant VoC VOCs was measured Wilcoxon signed-rank test World Health Organization [DOI] 10.1097/TP.0000000000004140 PMC 바로가기 [Article Type] Article
Evaluation of antibody titer kinetics and SARS-CoV-2 infections in a large cohort of healthcare professionals ten months after administration of the BNT162b2 vaccineBNT162b2 백신 투여 10개월 후 대규모 의료 전문가 집단에서 항체 역가 동역학 및 SARS-CoV-2 감염 평가Multicenter Study Published on 2022-07-012022-09-11 Journal: Journal of Immunological Methods [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법, [키워드] administration Anti-spike antibody Antibody Response Antibody titer BNT162b2 BNT162b2 vaccine booster dose Coverage COVID-19 COVID-19 vaccine decrease detectable difference dose Efficacy first dose follow-up period hcp Healthcare professional humoral Humoral response immune response Infection large cohort median titer mRNA vaccine multicenter multicenter study occurred population studies Post-vaccination infection Prevalence receiving Receptor-binding domain Roche Roche anti-SARS-CoV-2-S SARS-COV-2 infection SARS-CoV-2 infections serological test seronegative seronegatives seropositive serum serum antibody shown Spike protein Symptomatology the antibody response the median the receptor-binding domain the SARS-CoV-2 the spike protein time interval time intervals vaccination Vaccination strategy Vaccine vaccine efficacy vaccine response waning immunity was tested were measured within 6 months [DOI] 10.1016/j.jim.2022.113293 PMC 바로가기 [Article Type] Multicenter Study
Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum폴리(I:C) 플러스 명반과 관련된 SARS-CoV-2 삼량체 스파이크 단백질의 면역원성Article Published on 2022-06-302022-09-12 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] addition adjuvant adjuvants alum antibody B cell BALF Bronchoalveolar lavage fluid CD4 CD8 Cellular immune response Combination domain ELISA enzyme evaluated expected germinal centers IgA IgG IgG anti-spike antibody IgG1 IgG2a immunization immunogenicity immunosorbent in vitro inactivated induce intradermal route lung Lung inflammation mice Neutralization assay Neutralizing titer neutralizing titers neutrophil recruitment New Poly (I:C) poly(I:C positive prefusion produced producing Protein RBD reduced reduction in required SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 virus serum spike Spike protein Subtypes supported T cell Th1 Th1 phenotype the SARS-CoV-2 trimeric vaccination Vaccination strategy Vaccine [DOI] 10.3389/fimmu.2022.884760 PMC 바로가기 [Article Type] Article
Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19COVID-19에 대한 CoronaVac 백신 접종 후 12개월 이내에 체액 및 세포 면역 반응의 상태Article Published on 2022-06-282022-09-11 Journal: mBio [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] 12 months addition antibody approved baseline binding binding and neutralizing antibodies binding antibodies binding antibody CD4 CD8 Cell Cellular immune response cellular response Cellular responses central memory CoronaVac country COVID-19 COVID-19 pandemic COVID-19 vaccine COVID-19 vaccines Critical declined detectable dose effector memory Emergency use Endpoint enrolled Evidence functional gamma interferon granzyme B GzmB humoral Humoral and cellular immune responses IFN-γ IL-2 IL-5 immune memory immune persistence immune responses Inactivated vaccine interleukin interleukin 2 memory T cell memory T cells Month Neutralizing antibodies neutralizing antibody neutralizing antibody responses participant persistence produced provide RBD Receptor-binding domain reported response SARS-CoV-2 SARS-CoV-2 RBD second dose secretion seroconversion rate seropositive significantly higher status Stimulation T cells the cells the receptor-binding domain understanding vaccination vaccination schedule Vaccination strategy Vaccine [DOI] 10.1128/mbio.00181-22 PMC 바로가기 [Article Type] Article
Health technology assessment to employ COVID-19 serological tests as companion diagnostics in the vaccination campaign against SARS-CoV-2Article Published on 2022-06-242023-07-09 Journal: Clinical chemistry and laboratory medicine [Category] COVID19(2023년), [키워드] companion diagnostics COVID-19 Health technology assessment Serological tests Vaccination campaign Vaccination strategy [DOI] 10.1515/cclm-2022-0262
Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 VaccinesModerna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson 및 Sinopharm의 COVID-19 백신을 사용한 면역 후 IgA, IgG 및 중화 항체 반응의 비교Article Published on 2022-06-212022-09-12 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] age Analysis analyzed antibody Antibody titers AstraZeneca automated binding blood sample categories category Combination comparable Correlation analysis COVID-19 COVID-19 vaccines demonstrated DNA dose doses effective ELISA expression group groups Heterologous highest homologous IgA IgG immunogenic investigated lowest moderate Moderna mRNA vaccine negative correlation neutralization Neutralizing Neutralizing antibodies neutralizing antibody Older reactogenicity response sandwich ELISA SARS-CoV-2 sera significant increase significantly higher Sinopharm Spearman specific neutralizing antibody statistically Trial vaccination Vaccination strategy Vaccine vaccinee vaccinees vectored vaccine virus Virus neutralization Virus-specific IgG Volunteer [DOI] 10.3389/fimmu.2022.917905 PMC 바로가기 [Article Type] Article
Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies바이러스 유사 입자는 mRNA 유도 항체를 강화하기 위한 효율적인 도구입니다Article Published on 2022-06-162022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] antibodies Antibody Response Antibody responses approved boost COVID-19 economics Efficacy efficient Heterologous heterologous prime-boost heterologous prime-boost vaccination strategies homologous investigated maintain mRNA mRNA-1273 mRNA-1273 vaccine overcome Particle priming reduced regimen SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 variant the antibody response Vaccination strategy Vaccine vaccine candidate Virus-like particle virus-like particles VLP VLPs VOCs were used [DOI] 10.3389/fimmu.2022.864718 PMC 바로가기 [Article Type] Article